Martha Tarpay

1.6k total citations
18 papers, 497 citations indexed

About

Martha Tarpay is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Microbiology. According to data from OpenAlex, Martha Tarpay has authored 18 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Microbiology. Recurrent topics in Martha Tarpay's work include Pneumonia and Respiratory Infections (8 papers), Streptococcal Infections and Treatments (5 papers) and Bacterial Infections and Vaccines (5 papers). Martha Tarpay is often cited by papers focused on Pneumonia and Respiratory Infections (8 papers), Streptococcal Infections and Treatments (5 papers) and Bacterial Infections and Vaccines (5 papers). Martha Tarpay collaborates with scholars based in United States and United Kingdom. Martha Tarpay's co-authors include Regine Hakenbeck, Alexander Tomasz, David Welch, Melvin I. Marks, G R Istre, Michael P. Anderson, Aurora D. Pryor, Marinus Flux, Thomas W. Seale and Owen M. Rennert and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Clinical Microbiology and The Journal of Infectious Diseases.

In The Last Decade

Martha Tarpay

18 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martha Tarpay United States 11 312 163 122 114 98 18 497
Renée S. Blosser-Middleton United States 14 277 0.9× 167 1.0× 164 1.3× 119 1.0× 56 0.6× 17 460
E Vallée France 16 419 1.3× 266 1.6× 307 2.5× 157 1.4× 41 0.4× 31 642
A. Frémaux France 13 413 1.3× 72 0.4× 145 1.2× 123 1.1× 94 1.0× 32 506
William J. Holloway United States 13 318 1.0× 82 0.5× 112 0.9× 299 2.6× 43 0.4× 29 581
Monica M. Bullen Australia 5 403 1.3× 87 0.5× 125 1.0× 135 1.2× 87 0.9× 5 518
J S Redding United States 11 502 1.6× 238 1.5× 239 2.0× 136 1.2× 52 0.5× 16 716
Laurie Kilburn Canada 6 204 0.7× 87 0.5× 160 1.3× 139 1.2× 150 1.5× 7 454
Sarah Bakker New Zealand 8 372 1.2× 139 0.9× 56 0.5× 178 1.6× 65 0.7× 13 499
Birgitta Henriques Sweden 9 479 1.5× 77 0.5× 58 0.5× 254 2.2× 69 0.7× 11 715
A Kazmierczak France 13 206 0.7× 230 1.4× 179 1.5× 134 1.2× 29 0.3× 47 477

Countries citing papers authored by Martha Tarpay

Since Specialization
Citations

This map shows the geographic impact of Martha Tarpay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martha Tarpay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martha Tarpay more than expected).

Fields of papers citing papers by Martha Tarpay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martha Tarpay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martha Tarpay. The network helps show where Martha Tarpay may publish in the future.

Co-authorship network of co-authors of Martha Tarpay

This figure shows the co-authorship network connecting the top 25 collaborators of Martha Tarpay. A scholar is included among the top collaborators of Martha Tarpay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martha Tarpay. Martha Tarpay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Bentley, Jane H., David Miller, Richard K. Sterling, et al.. (2014). The effect of GSK2190915, a 5-lipoxygenase‐activating protein inhibitor, on exercise-induced bronchoconstriction. Allergy and Asthma Proceedings. 35(2). 126–133. 6 indexed citations
2.
Yeh, Fawn, Everett R. Rhoades, Martha Tarpay, & June E. Eichner. (2010). Advantages of Video Questionnaire in Estimating Asthma Prevalence and Risk Factors for School Children: Findings From an Asthma Survey in American Indian Youth. Journal of Asthma. 47(7). 711–717. 2 indexed citations
3.
Kerwin, Edward, Martha Tarpay, Michael Noonan, et al.. (2006). Safety and Efficacy of a New Albuterol Hydrofluoroalkane Formulation for Treating Asthma Symptoms in Children Two to Less Than Four Years of Age. Pediatric Asthma Allergy & Immunology. 19(2). 81–90. 2 indexed citations
4.
Busse, W., et al.. (2006). Phase 2/3 Study of the Novel Vaccine Amb a 1 Immunostimulatory Oligodeoxyribonucleotide Conjugate AIC in Ragweed-Allergic Adults. Journal of Allergy and Clinical Immunology. 117(2). S88–S89. 10 indexed citations
5.
Istre, G R, et al.. (1987). Invasive Disease Due to Streptococcus pneumoniae in an Area with a High Rate of Relative Penicillin Resistance. The Journal of Infectious Diseases. 156(5). 732–735. 76 indexed citations
6.
Tarpay, Martha, Stephen A. Chartrand, Michael Marks, & A C Cox. (1984). The extended microbiology of group a streptococcal pharyngitis. Observations during a double-blind controlled study of cephalexin twice versus four-times daily. Infection. 12(3). 181–184. 6 indexed citations
7.
Tarpay, Martha, David Welch, & Melvin I. Marks. (1982). In vitro Activity of Moxalactam and Cefoperazone against <i>Streptococcus pneumonia</i><i>e</i> with Differing Susceptibilities to Penicillin. Chemotherapy. 28(4). 261–266. 6 indexed citations
8.
Tarpay, Martha, et al.. (1982). In vitro activity of antibiotics commonly used in the treatment of otitis media against Streptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy. 22(1). 145–147. 16 indexed citations
9.
Tarpay, Martha. (1982). Cefaclor Therapy Twice Daily for Acute Otitis Media. American journal of diseases of children. 136(1). 33–33. 10 indexed citations
10.
Marks, Melvin I., et al.. (1982). Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrobial Agents and Chemotherapy. 21(6). 939–943. 48 indexed citations
11.
Hakenbeck, Regine, Martha Tarpay, & Alexander Tomasz. (1980). Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 17(3). 364–371. 183 indexed citations
12.
Tarpay, Martha, David Welch, & Melvin I. Marks. (1980). Antimicrobial susceptibility testing of Streptococcus pneumoniae by micro-broth dilution. Antimicrobial Agents and Chemotherapy. 18(4). 579–581. 24 indexed citations
13.
Tarpay, Martha, et al.. (1980). Fatal streptococcus pneumoniae type III sepsis in mother and infant. American Journal of Obstetrics and Gynecology. 136(2). 257–257. 11 indexed citations
14.
Tarpay, Martha, et al.. (1979). Septicemia in Children With Cancer. Southern Medical Journal. 72(2). 132–135. 7 indexed citations
15.
Tarpay, Martha, et al.. (1979). Recurrent Group B Streptococcal Infections: Report of Three Cases. Scandinavian Journal of Infectious Diseases. 11(1). 35–38. 18 indexed citations
16.
Seale, Thomas W., et al.. (1979). Serotypes andAntibiotic Susceptibilities ofPseudomonas aeruginosa Isolates fromSingle SputaofCystic Fibrosis Patients. 2 indexed citations
17.
Seale, Thomas W., et al.. (1979). Serotypes and Antibiotic Susceptibilities of Pseudomonas aeruginosa Isolates from Single Sputa of Cystic Fibrosis Patients. Journal of Clinical Microbiology. 9(1). 72–78. 55 indexed citations
18.
Tarpay, Martha. (1978). Importance of Antimicrobial Susceptibility Testing of Streptococcus pneumoniae. Antimicrobial Agents and Chemotherapy. 14(4). 628–629. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Renée S. Blosser-Middleton Breakdown of academic impact, for papers by E Vallée Breakdown of academic impact, for papers by A. Frémaux Breakdown of academic impact, for papers by William J. Holloway Breakdown of academic impact, for papers by Monica M. Bullen Breakdown of academic impact, for papers by J S Redding Breakdown of academic impact, for papers by Laurie Kilburn Breakdown of academic impact, for papers by Sarah Bakker Breakdown of academic impact, for papers by Birgitta Henriques Breakdown of academic impact, for papers by A Kazmierczak
Rankless by CCL
2026